Effects of (-)-menthol on arylamine n-acetyltransferase activity in human liver tumor cells

American Journal of Chinese Medicine

Volumn 29, Issue 2, 2001, Pages 321-329

  Lin, Jing Pin ^a   Li, Yuh Ching ^a   Lin, Weng Chuan ^b   Hsieh, Ching Liang ^b   Chung, Jing Gung ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Cluing Tai Institute of Health Sciences and Technology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARYLAMINE ACETYLTRANSFERASE; MENTHOL;

ARTICLE; CELL CULTURE; CYTOSOL; DOSE RESPONSE; ENZYMOLOGY; HUMAN; KINETICS; LIVER TUMOR; METABOLISM; TIME;

ANTINEOPLASTIC AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; LIVER NEOPLASMS; MENTHOL; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0035230644     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X01000344     Document Type: Article

References (23)

1. Blum, M., D.M. Grant, O.W. Mcbride, H. Heim and U.A. Meyer. Human arylamine N-acetyltransferase genes: Isolation, characterization, chromosomal localization, and functional expression. DNA Cell Biol. 9: 193-203, 1990
2. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976
3. Cleland, W.W. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29:1-32,1967.
4. Einisto, P., M. Watanabe, M. Ishidate and T. Nohmi. Mutagenicity of 30 chemicals in S. typhinmriwn possessing different nitroreductase or O-acetyltransferase activities. Mutation Res. 259:95-102,1991.
5. Evans, D.A.P. N-acetyltransferase. Pharmacol. Ther. 42: 157-234, 1989.
6. Cartwright, R.A., R.W. Glashami, H.J. Rogers, R.A. Ahmed, D. Barham-Hall, E. Higgens and M.A. Kahn. Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet. 2: 842-846, 1982.
7. Chung, J.G., G.N. Levy and W.W. Weber. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-Nats slow acetylator congenic mice. Drug Metab. Dispos. 21: 1057-1063, 1993.
8. Grant, D.M., M. Blum, M. Beer and U.A. Meyer. Monomorphic and polymorphic human arylamine N-acetyltransferase : A comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39: 184-191, 1991.
9. Iletti, K.F., B.M. David, P. Detchon, W.M. Castlcdon and R. Kwa. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47: 1466-1469, 1987.
10. Lang, N.P., D.Z.J. Chu, C.F. Hunter, D.C. Kendall, T.J. Flamang and F.F. Kadlubar. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg. 121:1259-1261,1986.
11. Lang, N.P., M.A. Butter, J. Massengill, M. Lawson, R.C. Stotts, M. Hauer-Jensen and F.F. Kadluhar. Rapid metabolic phenotypcs for acetyltransferase and cytochrome p4501A2 and putative exposure to food-borne heterocyclic amines increase the risk of for colorectal cancer of polyps. Cancer Epidemiol. Biomarkers Press. 3: 675-682, 1994.
12. Levy, G.N., J.G. Chung and WAV. Weber. 2-aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis. 15: 353-357, 1994.
13. Macfoy, C.A. and Cline, E.I. In Vitro antibacterial activities of three plants used in traditional medicine in Sierra Leone. J. Etlinopharinacol. 28: 323-327, 1990.
14. Miller, E.G. and J.A. Miller. Search for the ultimate chemicals carcinogens and their reaction with cellular macromolecules. Cancer 47:2327-2345,1981.
15. Minchin, R.F., P.T. Reeves, C.H. Teitel, M.E. McManus, T. Mojarrabi, K.F. Ilett and F.F. Kadlubar. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185: 839-844, 1992.
16. Ohsako, S. and T. Deguchi. Cloning and expression of cDNAs for polymorphic and monomorphic N-acetyltransferase from human liver. J. Biol. Chem. 265: 4630-4634, 1990.
17. Pattnaik, S., V.R. Subramanyan, M. Bapaji and C.R. Kole. Antibacterial and antifungal activity of aromatic constituentsl. Microbios. 89: 39-46, 1997.
18. Ruch, R.J. and K. Sigler. Growth inhibition of rat liver epithelial tumor cells by monoterpenes dose not involve Ras plasma membrane association. Carcinogenesis. 15: 787-789, 1994.
19. Russin, W.W., J.D. Hoesly, C.E. Elson, M.A. Tanner and M.N. Gould. Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis. 10: 2161-2164, 1989.
20. Smith, G., L.A. Stanley, E. Sim, R.C. Strange and C.R. Wolf. Metabolic polymorphisms and cancer susceptibility. Cancer Siirv. 25: 27-65,1995.
21. Weber, WAV. and D.W. Hein. N-acetylation pharmacogenetics. Pharmacol. Rev. 37: 25-99, 1985.
22. Weber, WAV. The acetylator genes and drug response, pp. 21-55. Oxford University Press, New York, 1987.
23. Wu, L.T. and J.G. Chung. Effects of vitamin C on arylamine N-acetyltransferase activity in human liver rumour cells. Anticancer Res. 18:3481-3486, 1998.